ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC), an aggressive variant of breast cancer characterized by lack of expression of the estrogen receptor (ER) , progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER-2) accounts for 15-26% of breast cancer[3,4].